Catheter-associated and nosocomial urinary tract infections: Antibiotic resistance and influence on commonly used antimicrobial therapy

International Urology and Nephrology

Volumn 41, Issue 3, 2009, Pages 461-464

  Milan, Potic B ^a   Ivan, Ignjatovic M ^a  

^a Clinical Center Ni   (Serbia)

Author keywords

Community infection; Empirical therapy; Nosocomial infection

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; CATHETER INFECTION; COMMUNITY ACQUIRED URINARY TRACT INFECTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSOCOMIALY ACQUIRED URINARY TRACT INFECTION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 67649963248     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9468-y     Document Type: Article

References (21)

1. Merle V, Jeanin-Marie G, Hubert B et al (2002) Nosocomial urinary tract infections in urologic patients: Assessment of a prospective surveillance program including 10,000 patients. Eur Urol 41:483-489. doi: 10.1016/S0302-2838(02)00069-6
2. Wagenlehner FME, Loibl E, Vogel H et al (2006) Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management. J Antimicrob Agents 28:86-90. doi: 10.1016/ j.ijantimicag.2006.05.011
3. Wagenlehner FME, Naber KG (2006) Treatment of bacterial urinary tract infections: Presence and future. Eur Urol 49:235-244. doi: 10.1016/ j.eururo.2005.12.017
4. Kunin CM (2006) Urinary-catheter-associated infections in elderly. Int J Antimicrob Agents 28:78-81. doi: 10.1016/j.ijantimicag.2006.05.013
5. Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7:342-347
6. Bouza E, San Juan R, Munoz P et al (2001) On behalf of the co-operative group of the European study group on nosocomial infections (ESGNI). A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003). Clin Microbiol Infect 7:523-531. doi: 10.1046/ j.1198-743x.2001.00326.x
7. Richards CL (2004) Urinary tract infections in the frail elderly: Issues for diagnosis, treatment and prevention. Int Urol Nephrol 36:457-463. doi: 10.1007/s11255-004-4870-6
8. Johansen TEB, Cek M, Naber K et al (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51:1100-1112. doi: 10.1016/j.eururo.2006.08.012
9. Gastmeier P, Kampf G, Wischnewski N (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38:37-49. doi: 10.1016/S0195-6701(98)90173-6
10. Warren JW (2001) Catheter-associated urinary tract infections. J Antimicrob Agents 17:299-303. doi: 10.1016/S0924-8579(00)00359-9
11. Yeniyol CÖ, Tuna A, Yener H et al (2003) Bacterial colonization of double J stents and bacterial frequency. Int Urol Nephrol 34:199-202. doi: 10.1023/A:1023285422278
12. Akay AF, Aflay U, Gedik A et al (2007) Risk factors for lower urinary tract infection and bacterial stent colonisation in patients with a double J ureteral stent. Int Urol Nephrol 39:95-98. doi: 10.1007/ s11255-006-9150-1
13. Agodi A, Barchitta M, Anzaldi A et al (2007) Active surveillance of nosocomial infections in urologic patients. Eur Urol 51:247-254. doi: 10.1016/j.eururo.2006.05.027
14. Metlay JP, Storm BL, Asch DA (2003) Prior antimicrobial drug exposure: A risk factor for trimethoprim- sulfomethoxazole-resistance urinary tract infections. J Antimicrob Chemother 51:963-970. doi: 10.1093/jac/dkg146
15. Kurutepe S, Surukuoglu S, Sezgin C et al (2005) Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 58:159-161
16. Wright SW, Wrenn KD, Haynes ML (1999) Trimethoprim-sulfomethoxazole resistance among urinary coliform isolates. J Gen Intern Med 14:606-609. doi: 10.1046/j.1525-1497.1999.10128.x
17. Olafson M, Kristinsson KG, Sigurdsson JA (2000) Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs. Scand J Prim Health Care 18:35-38. doi: 10.1080/02813430050202532
18. Nickel JC (2005) Management of urinary tract infections: Historical perspective and current strategies part 2-modern menagement. J Urol 173:1-6. doi: 10.1097/01.ju.0000159198.83103.01
19. Drews SJ, Poutanen SM, Mazzulli T et al (2005) Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherischia coli isolates. J Clin Microbiol 43:4218-4220. doi: 10.1128/ JCM.43.8.4218-4220.2005
20. Khuri SF, Henderson WG, DePalma RG et al (2005) Participants in the VA National Surgical Quality Improvement. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242:326-341
21. Burke JP (2003) Infection control - a problem for patient safety. N Engl J Med 348:651-656. doi: 10.1056/NEJMhpr020557